SCHEMBL5352004

SCHEMBL5352004

N#C[C@@H]1CCCN1C(=O)[C@@H](N)CSCC(=O)NCc1cccnc1

nearest known ligand 0.61

Predicted protein targets (top 5)

geneUniProtsupporting neighboursconfidence
DPP4 P27487 20/20 0.61
DPP8 Q6V1X1 16/20 0.61
DPP7 Q9UHL4 13/20 0.53
DPP9 Q86TI2 13/20 0.53
FAP Q12884 7/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Trifluoroacetic Acid SCHEMBL5352740 0.94 DPP4 (0.58) DPP4DPP8DPP7DPP9FAP
SCHEMBL14558292 0.84 DPP4 (0.61) DPP4DPP8DPP7DPP9FAP
SCHEMBL5345414 0.83 CYP3A4 (0.52) DPP4DPP8DPP7
SCHEMBL6100492 0.82 PREP (0.46) DPP4DPP8DPP7DPP9FAP
SCHEMBL3554780 0.77 DPP4 (1.00) DPP4DPP8DPP7DPP9FAP
SCHEMBL14392573 0.77 DPP4 (1.00) DPP4DPP8DPP7DPP9FAP
SCHEMBL3554784 0.77 DPP4 (1.00) DPP4DPP8DPP7DPP9FAP
SCHEMBL6453066 0.71 DPP4 (1.00) DPP4DPP8DPP7DPP9FAP
SCHEMBL5359276 0.70 DPP4 (0.55) DPP4DPP8DPP7DPP9FAP
SCHEMBL4412142 0.68 DPP4 (0.78) DPP4DPP8DPP7DPP9FAP

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7189728-B2 Inhibitors of dipeptidyl peptidase IV FERRING, BV (NL) 2007-03-13 US claimed
EP-1693365-A1 Inhibitors of dipeptidyl peptidase IV FERRING B.V. (NL) 2006-08-23 EP claimed
US-20030216450-A1 Inhibitors of dipeptidyl peptidase IV FERRING BV (NL) 2003-11-20 US claimed
EP-1282600-A1 INHIBITORS OF DIPEPTIDYL PEPTIDASE IV Ferring BV (NL) 2003-02-12 EP claimed
WO-2001081304-A1 INHIBITORS OF DIPEPTIDYL PEPTIDASE IV FERRING BV (NL) 2001-11-01 WO claimed
US-7189728-B2 Inhibitors of dipeptidyl peptidase IV FERRING, BV (NL) 2007-03-13 US disclosed
US-7189728-B2 Inhibitors of dipeptidyl peptidase IV FERRING, BV (NL) 2007-03-13 US disclosed
US-7189728-B2 Inhibitors of dipeptidyl peptidase IV FERRING, BV (NL) 2007-03-13 US disclosed
EP-1693365-A1 Inhibitors of dipeptidyl peptidase IV FERRING B.V. (NL) 2006-08-23 EP disclosed
US-20030216450-A1 Inhibitors of dipeptidyl peptidase IV FERRING BV (NL) 2003-11-20 US disclosed
EP-1282600-A1 INHIBITORS OF DIPEPTIDYL PEPTIDASE IV Ferring BV (NL) 2003-02-12 EP disclosed
WO-2001081304-A1 INHIBITORS OF DIPEPTIDYL PEPTIDASE IV FERRING BV (NL) 2001-11-01 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030216450-A1 Inhibitors of dipeptidyl peptidase IV DPP4, DPP7, DPP8 DPP4 1/4885DPP8 3/4885DPP7 2/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.